PharmaBoardroom

Pavla Rozmarová – Clinical Research Associate Manager…

Pavla Rozmarová, clinical research associate manager & regional OD for the Czech affiliate of German CRO Scope International, describes how the…

Frank Swaelens – General Manager, IQVIA Belgium &…

Frank Swaelens, general manager of IQVIA in Belgium and Luxembourg, offers insights into the healthcare and life science ecosystem of Belgium and…

Mazen Dalati – General Manager Middle East, Alcon

Mazen Dalati, general manager for Alcon in the Middle East, discusses the importance of the Middle East for the largest eye care company in the world,…

Bing Xu – General Manager, Vital River Laboratories, China

Bing Xu, GM of Vital River Laboratories, shares the company’s development in the last 20 years; the challenges of advantages of their JV with…

Elias Chabtini – Founder & CEO, Medica Group, UAE

Medica Group provides medical aesthetics, cosmetics and dermatology, and plastic surgery products and equipment across the Middle East and South East…

Françoise Smets – Dean, Faculty of Medicine &…

Françoise Smets, dean of the Faculty of Medicine and Dentistry at Université Catholique de Louvain (UCLouvain), introduces the innovation and…

Georg Schroeckenfuchs – President, Middle East & Head,…

Georg Schroeckenfuchs, Novartis’ president for the Middle East and head of MEA cluster, is a 32-year veteran of the pharmaceutical industry and…

David Kershenobich Stalnikowitz – Director General,…

Dr David Kershenobich Stalnikowitz, director-general of the Salvador Zubirán National Institute of Medical Sciences and Nutrition (INCMNSZ) shares…

Merck’s EUR 250 Million Investment in New Swiss Biotech…

German biopharma giant Merck is investing EUR 250 million in a new Swiss biotech development facility; underscoring the company’s reliance on…

Chiesi Moves into Rare Diseases & the US Market

Italian mid-cap firm Chiesi is continuing its expansion in the USA market with the launch of a Boston-based subsidiary focusing on rare and ultra-rare…

US FDA New Drug Approvals 2019 Snapshot

Annual numbers of new molecular entities (NMEs) and biologics license applications (BLAs) approved by the FDA's Center for Drug Evaluation and…

Barbara Lopez Kunz – CEO, Drug Information Association…

Barbara Lopez Kunz, CEO of the Drug Information Association (DIA) in the USA, outlines the association’s four key areas of focus – regulatory…

Tagged with